Cargando…
Bias and inconsistency in the estimation of tumour mutation burden
BACKGROUND: Tumour mutation burden (TMB), defined as the number of somatic mutations per megabase within the sequenced region in the tumour sample, has been used as a biomarker for predicting response to immune therapy. Several studies have been conducted to assess the utility of TMB for various can...
Autores principales: | Makrooni, Mohammad A., O’Sullivan, Brian, Seoighe, Cathal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347149/ https://www.ncbi.nlm.nih.gov/pubmed/35918650 http://dx.doi.org/10.1186/s12885-022-09897-3 |
Ejemplares similares
-
Comprehensive and realistic simulation of tumour genomic sequencing data
por: O’Sullivan, Brian, et al.
Publicado: (2023) -
Random-effects meta-analysis of effect sizes as a unified framework for gene set analysis
por: Makrooni, Mohammad A., et al.
Publicado: (2022) -
vcfView: An Extensible Data Visualization and Quality Assurance Platform for Integrated Somatic Variant Analysis
por: O’Sullivan, Brian, et al.
Publicado: (2020) -
The minimizer Jaccard estimator is biased and inconsistent
por: Belbasi, Mahdi, et al.
Publicado: (2022) -
Inference of Candidate Germline Mutator Loci in Humans from Genome-Wide Haplotype Data
por: Seoighe, Cathal, et al.
Publicado: (2017)